Skip to content
Disclosery

Broadfin Capital, LLC

Follow

13F filer, CIK 1511901, New York, NY

Broadfin Capital, LLC reported $540,905,000 across 44 holdings for the quarter ended 2019-09-30, in a 13F-HR filed 2019-11-14. Its ten largest share positions make up 52.41% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001511901-19-000006

Period
2019-09-30
Reported value
$541M
Holdings
44
Top 10 weight
52.41%
New
14
Sold out
9

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AMARIN CORP PLCadded+1,278,011$19.4M
INTERSECT ENT INCnew+779,134$13.3M
ABBVnew+154,500$11.7M
WRIGHT MED GROUP N Vadded+492,100$10.2M
PROGENICS PHARMACEUTICALS INnew+1,583,925$8.01M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ARATANA THERAPEUTICS INCexited-7,258,135-$37.5M
NEVRO CORPreduced-337,755-$29M
HRTXreduced-559,761-$10.4M
CPRXreduced-1,884,767-$10M
DXCMexited-63,300-$9.48M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2019

Share positions as resolved from 13F-HR 0001511901-19-000006, largest first. % of portfolio is the value over $318,659,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AMARIN CORP PLCAMARIN CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 2,078,799 shares; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 291,000 shares; 2019Q3: 1,569,011 shares 1,569,011$23.8M7.46%+1,278,011
BIOHAVEN PHARMACEUTICAL HOL…BIOHAVEN PHARMACEUTICAL HOLDINQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 129,300 shares; 2019Q1: 246,900 shares; 2019Q2: 676,879 shares; 2019Q3: 532,591 shares 532,591$22.2M6.97%-144,288
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 912,987 shares; 2018Q2: 4,146,605 shares; 2018Q3: 4,894,361 shares; 2018Q4: 5,951,153 shares; 2019Q1: 4,328,303 shares; 2019Q2: 1,559,299 shares; 2019Q3: 1,131,101 shares 1,131,101$20.6M6.46%-428,198Timeline
BIODELIVERY SCIENCES INTL INBIODELIVERY SCIENCES INTL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 4,278,819 shares; 2018Q2: 4,278,819 shares; 2018Q3: 4,375,066 shares; 2018Q4: 4,375,066 shares; 2019Q1: 4,375,066 shares; 2019Q2: 4,281,943 shares; 2019Q3: 4,300,066 shares 4,300,066$18.1M5.68%+18,123
ALLERGAN PLCALLERGAN PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 114,804 shares; 2019Q3: 96,504 shares 96,504$16.2M5.1%-18,300
EIGER BIOPHARMACEUTICALS INCEIGER BIOPHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 143,300 shares; 2019Q1: 193,300 shares; 2019Q2: 1,656,137 shares; 2019Q3: 1,367,377 shares 1,367,377$14M4.4%-288,760
INTERSECT ENT INCINTERSECT ENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 234,200 shares; 2018Q4: 287,900 shares; 2019Q1: 263,500 shares; 2019Q2: not reported; 2019Q3: 779,134 shares 779,134$13.3M4.16%new
SIENTRA INCSIENTRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 1,400,000 shares; 2019Q3: 2,001,895 shares 2,001,895$13M4.07%+601,895
NEVRO CORPNEVRO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 744,415 shares; 2019Q1: 622,615 shares; 2019Q2: 488,265 shares; 2019Q3: 150,510 shares 150,510$12.9M4.06%-337,755
AVADEL PHARMACEUTICALS, PLCAVADEL PHARMACEUTICALS, PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 2,624,663 shares; 2018Q2: 2,724,663 shares; 2018Q3: 2,792,773 shares; 2018Q4: 3,102,673 shares; 2019Q1: 3,102,673 shares; 2019Q2: 3,102,673 shares; 2019Q3: 3,102,673 shares 3,102,673$12.9M4.05%0
WRIGHT MED GROUP N VWRIGHT MED GROUP N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 126,400 shares; 2019Q3: 618,500 shares 618,500$12.8M4%+492,100
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 154,500 shares 154,500$11.7M3.67%newTimeline
SOCIETAL CDMO INCSOCIETAL CDMO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 2,236,025 shares; 2018Q2: 2,048,025 shares; 2018Q3: 2,048,025 shares; 2018Q4: 2,048,025 shares; 2019Q1: 1,909,995 shares; 2019Q2: 1,561,617 shares; 2019Q3: 987,760 shares 987,760$10.9M3.43%-573,857
VRAYQVIEWRAY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 250,000 shares; 2018Q4: 866,500 shares; 2019Q1: 866,500 shares; 2019Q2: 866,500 shares; 2019Q3: 3,001,361 shares 3,001,361$8.7M2.73%+2,134,861Timeline
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 80,100 shares; 2018Q3: not reported; 2018Q4: 240,909 shares; 2019Q1: 395,309 shares; 2019Q2: 316,619 shares; 2019Q3: 177,016 shares 177,016$8.59M2.7%-139,603
PROGENICS PHARMACEUTICALS INPROGENICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 1,583,925 shares 1,583,925$8.01M2.51%new
RETROPHIN INCRETROPHIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 1,178,226 shares; 2018Q2: 1,048,693 shares; 2018Q3: 938,214 shares; 2018Q4: 1,016,114 shares; 2019Q1: 1,016,114 shares; 2019Q2: 1,053,314 shares; 2019Q3: 610,414 shares 610,414$7.08M2.22%-442,900
STRATA SKIN SCIENCES INCSTRATA SKIN SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 203,346 shares; 2018Q2: 2,943,819 shares; 2018Q3: 2,181,363 shares; 2018Q4: 2,171,363 shares; 2019Q1: 2,866,323 shares; 2019Q2: 3,256,615 shares; 2019Q3: 2,916,915 shares 2,916,915$6.27M1.97%-339,700
STRONGBRIDGE BIOPHARMA PLCSTRONGBRIDGE BIOPHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 2,793,752 shares; 2018Q2: 2,340,649 shares; 2018Q3: 2,563,096 shares; 2018Q4: 2,821,722 shares; 2019Q1: 2,792,049 shares; 2019Q2: 2,544,839 shares; 2019Q3: 2,578,003 shares 2,578,003$6.16M1.93%+33,164
EXICURE INCEXICURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 2,311,906 shares 2,311,906$5.85M1.84%new
ZOGENIX INC.ZOGENIX INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 537,380 shares; 2018Q2: 622,380 shares; 2018Q3: 657,898 shares; 2018Q4: 535,998 shares; 2019Q1: 371,698 shares; 2019Q2: 344,762 shares; 2019Q3: 138,037 shares 138,037$5.53M1.73%-206,725
SOL GEL TECHNOLOGIESSOL GEL TECHNOLOGIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 647,700 shares; 2018Q2: 647,700 shares; 2018Q3: 847,700 shares; 2018Q4: 847,700 shares; 2019Q1: 847,700 shares; 2019Q2: 730,100 shares; 2019Q3: 563,300 shares 563,300$5.06M1.59%-166,800
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 249,000 shares 249,000$4.86M1.52%newTimeline
XGNEXAGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 311,284 shares 311,284$4.82M1.51%newTimeline
ICUIICU MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 30,000 shares 30,000$4.79M1.5%newTimeline
QUOTIENT LTDQUOTIENT LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 439,700 shares; 2018Q3: 804,700 shares; 2018Q4: 1,697,582 shares; 2019Q1: 1,098,656 shares; 2019Q2: 639,756 shares; 2019Q3: 613,429 shares 613,429$4.77M1.5%-26,327
CPRXCATALYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 6,812,764 shares; 2018Q2: 6,772,764 shares; 2018Q3: 5,136,264 shares; 2018Q4: 6,268,298 shares; 2019Q1: 5,856,998 shares; 2019Q2: 2,765,070 shares; 2019Q3: 880,303 shares 880,303$4.67M1.47%-1,884,767Timeline
ANTARES PHARMA INCANTARES PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 4,673,247 shares; 2018Q2: 4,623,247 shares; 2018Q3: 4,623,247 shares; 2018Q4: 3,444,147 shares; 2019Q1: 2,643,947 shares; 2019Q2: 1,744,147 shares; 2019Q3: 1,336,700 shares 1,336,700$4.47M1.4%-407,447
SIBNSI BONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 312,898 shares; 2019Q3: 223,291 shares 223,291$3.95M1.24%-89,607Timeline
DERMIRA INCDERMIRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 579,600 shares 579,600$3.7M1.16%new
VCELVERICEL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 658,900 shares; 2018Q2: not reported; 2018Q3: 132,600 shares; 2018Q4: 190,000 shares; 2019Q1: 272,550 shares; 2019Q2: 258,150 shares; 2019Q3: 237,050 shares 237,050$3.59M1.13%-21,100Timeline
GW PHARMACEUTICALS PLCGW PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 175,030 shares; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 30,000 shares 30,000$3.45M1.08%new
NANOSTRING TECHNOLOGIES INCNANOSTRING TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 850,000 shares; 2018Q4: 720,600 shares; 2019Q1: 355,714 shares; 2019Q2: 74,786 shares; 2019Q3: 110,800 shares 110,800$2.39M0.75%+36,014
ADMAADMA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 720,529 shares; 2018Q2: 3,249,829 shares; 2018Q3: 4,463,829 shares; 2018Q4: 4,226,077 shares; 2019Q1: 1,479,243 shares; 2019Q2: 747,500 shares; 2019Q3: 505,900 shares 505,900$2.25M0.71%-241,600Timeline
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 1,581,416 shares; 2018Q2: 519,787 shares; 2018Q3: 291,213 shares; 2018Q4: 119,294 shares; 2019Q1: 207,998 shares; 2019Q2: 657,998 shares; 2019Q3: 98,237 shares 98,237$1.82M0.57%-559,761Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 1,877,502 shares; 2019Q1: 2,030,925 shares; 2019Q2: not reported; 2019Q3: 1,620,000 shares 1,620,000$1.75M0.55%newTimeline
LA JOLLA PHARMACEUTICAL COLA JOLLA PHARMACEUTICAL COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 1,656,720 shares; 2018Q2: 1,494,520 shares; 2018Q3: 2,053,991 shares; 2018Q4: 1,947,541 shares; 2019Q1: 1,994,911 shares; 2019Q2: 891,760 shares; 2019Q3: 181,844 shares 181,844$1.6M0.5%-709,916
AMAG PHARMACEUTICALS INCAMAG PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: 598,800 shares; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 100,000 shares 100,000$1.16M0.36%new
PALATIN TECHNOLOGIES INCPALATIN TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 1,047,310 shares 1,047,310$952K0.3%new

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SPYSTATE STR SPDR S&P 500 ETF T SHSput440,000$131Mnew
XBISPDR SERIES TRUST S&P BIOTECHput700,000$53.4Mnew
BIOHAVEN PHARMACEUTICAL HOL…BIOHAVEN PHARMACEUTICAL HOLDIN COMcall500,000$20.9M+100,000
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INC COMcall200,000$15.6M0
HRTXHERON THERAPEUTICS INC COMcall100,000$1.85M0

Sold out in Q3 2019

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ARATANA THERAPEUTICS INCARATANA THERAPEUTICS INC7,258,135$37.5Mshares
RETROPHIN INCRETROPHIN INC500,000$10Mput
DXCMDEXCOM INC63,300$9.48Mshares
INCYINCYTE CORP66,600$5.66Mshares
OPTINOSE INCOPTINOSE INC595,900$4.22Mshares
MYGNMYRIAD GENETICS INC123,785$3.44Mshares
RETROPHIN INCRETROPHIN INC150,000$3.01Mcall
ADAMAS PHARMACEUTICALS INCADAMAS PHARMACEUTICALS INC441,088$2.73Mshares
MATINAS BIOPHARMA HLDGS INCMATINAS BIOPHARMA HLDGS INC766,708$657Kshares

How Q3 2019 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001511901-19-000006 base2019-11-14acceptance time not in the bulk data set